152 related articles for article (PubMed ID: 6243130)
1. Plasma beta-endorphin responses to somatostatin, thyrotropin-releasing hormone, or vasopressin in Nelson's syndrome.
Oki S; Nakai Y; Nakao K; Imura H
J Clin Endocrinol Metab; 1980 Jan; 50(1):194-7. PubMed ID: 6243130
[TBL] [Abstract][Full Text] [Related]
2. Effects of bromocriptine and cyproheptadine on basal and corticotropin-releasing factor (CRF)-induced ACTH release in a patient with Nelson's syndrome.
Hirata Y; Nakashima H; Uchihashi M; Tomita M; Fujita T; Ikeda M
Endocrinol Jpn; 1984 Oct; 31(5):619-26. PubMed ID: 6097444
[TBL] [Abstract][Full Text] [Related]
3. Corticotropin-releasing hormone (CRH) stimulation in Nelson's syndrome: response of adrenocorticotropin secretion to pulse injection and continuous infusion of CRH.
Oldfield EH; Schulte HM; Chrousos GP; Gold PW; Benker G; Peterson RE; Cutler GB; Loriaux DL
J Clin Endocrinol Metab; 1986 May; 62(5):1020-6. PubMed ID: 3007552
[TBL] [Abstract][Full Text] [Related]
4. Concomitant secretion of Y-MSH with ACTH and beta-endorphin in humans.
Nakao K; Oki S; Tanaka I; Nakai Y; Imura H
J Clin Endocrinol Metab; 1980 Nov; 51(5):1205-7. PubMed ID: 6252236
[TBL] [Abstract][Full Text] [Related]
5. Concomitant secretion of adrenocorticotropin, beta-endorphin, and gamma-melanotropin from perfused pituitary tumor cells of Cushing's disease: effects of lysine vasopressin, rat median eminence extracts, thyrotropin-releasing hormone, and luteinizing hormone-releasing hormone.
Oki S; Nakao K; Tanaka I; Horii K; Nakai Y; Shimbo S; Watanabe M; Nakane T; Kuwayama A; Kageyama N; Imura H
J Clin Endocrinol Metab; 1981 Jan; 52(1):42-9. PubMed ID: 6256404
[TBL] [Abstract][Full Text] [Related]
6. Hyperprolactinemia in Cushing's disease and Nelson's syndrome.
Yamaji T; Ishibashi M; Teramoto A; Fukushima T
J Clin Endocrinol Metab; 1984 May; 58(5):790-5. PubMed ID: 6323516
[TBL] [Abstract][Full Text] [Related]
7. Effects of various neuropeptides on the secretion of proopiomelanocortin-derived peptides by a cultured pituitary adenoma causing Nelson's syndrome.
Shibasaki T; Masui H
J Clin Endocrinol Metab; 1982 Nov; 55(5):872-6. PubMed ID: 6126487
[TBL] [Abstract][Full Text] [Related]
8. Corticotropin-releasing factor (ovine) and vasopressin exert a synergistic effect on adrenocorticotropin release in man.
Lamberts SW; Verleun T; Oosterom R; de Jong F; Hackeng WH
J Clin Endocrinol Metab; 1984 Feb; 58(2):298-303. PubMed ID: 6319446
[TBL] [Abstract][Full Text] [Related]
9. Plasma ACTH and cortisol responses to TRF, vasopressin or hypoglycemia in cushing's disease and nelson's syndrome.
Krieger DT; Luria M
J Clin Endocrinol Metab; 1977 Feb; 44(2):361-8. PubMed ID: 190254
[TBL] [Abstract][Full Text] [Related]
10. ACTH response to TRH and somatostatin in Nelson's syndrome.
Ambrosi B; Bochicchio D; Sartorio A; Rondena M; Riva E
Horm Metab Res; 1982 Mar; 14(3):164. PubMed ID: 6121749
[No Abstract] [Full Text] [Related]
11. In vitro secretion of ACTH, beta-endorphin and beta-lipotropin in Cushing's disease and Nelson's syndrome.
Lüdecke DK; Westphal M; Schabet M; Höllt V
Horm Res; 1980; 13(4-5):259-79. PubMed ID: 6268513
[TBL] [Abstract][Full Text] [Related]
12. Plasma ACTH levels and beta-endorphin-like immunoreactivity following administration of luteinizing hormone-releasing hormone in Nelson's syndrome.
Kasperlik-Załuska AA; Abdel-Fattah MH; Jeske W; Puciłowska J
Eur J Obstet Gynecol Reprod Biol; 1986 Apr; 21(4):199-205. PubMed ID: 3011530
[TBL] [Abstract][Full Text] [Related]
13. Cyproheptadine treatment of Nelson's syndrome: restoration of plasma ACTH circadian periodicity and reversal of response to TRF.
Krieger DT; Condon EM
J Clin Endocrinol Metab; 1978 Feb; 46(2):349-52. PubMed ID: 220278
[TBL] [Abstract][Full Text] [Related]
14. ACTH and beta-endorphin secretion by three corticotrophic adenomas in culture. Effects of culture time, dexamethasone, vasopressin and synthetic corticotrophin releasing factor.
Oosterom R; Verleun T; Uitterlinden P; Hackeng WH; Burbach JP; Wiegant VM; Lamberts SW
Acta Endocrinol (Copenh); 1984 May; 106(1):21-9. PubMed ID: 6328819
[TBL] [Abstract][Full Text] [Related]
15. ACTH responses to somatostatin, valproic acid and dexamethasone in Nelson's syndrome.
Kasperlik-Załuska AA; Zgliczyński W; Jeske W; Zdunowski P
Neuro Endocrinol Lett; 2005 Dec; 26(6):709-12. PubMed ID: 16380696
[TBL] [Abstract][Full Text] [Related]
16. Sustained improvements in plasma ACTH and clinical status in a patient with Nelson's syndrome treated with pasireotide LAR, a multireceptor somatostatin analog.
Katznelson L
J Clin Endocrinol Metab; 2013 May; 98(5):1803-7. PubMed ID: 23539733
[TBL] [Abstract][Full Text] [Related]
17. [Studies of the basal secretion and the response to TRH (thyrotropin-relapsing factor) of TSH (thyrotropin) and prolactin in Cushing's syndrome and Nelson's syndrome (author's transl)].
Luton JP; Molinie P; Strauch G; Guilhaume B; Bricaire H
Sem Hop; 1981 May 8-15; 57(17-18):841-9. PubMed ID: 6262921
[TBL] [Abstract][Full Text] [Related]
18. Presence of immunoreactive beta-endorphin in plasma of patients with Nelson's syndrome and Addison's disease.
Nakai Y; Nakao K; Oki S; Imura H; Li CH
Life Sci; 1978 Dec; 23(23):2293-8. PubMed ID: 732531
[No Abstract] [Full Text] [Related]
19. Pituitary adenomas that caused Cushing's disease or Nelson's syndrome are not responsive to ovine corticotropin-releasing factor in vitro.
Shibasaki T; Nakahara M; Shizume K; Kiyosawa Y; Suda T; Demura H; Kuwayama A; Kageyama N; Benoit R; Ling N
J Clin Endocrinol Metab; 1983 Feb; 56(2):414-6. PubMed ID: 6130101
[TBL] [Abstract][Full Text] [Related]
20. Sustained remission of Nelson's syndrome after stopping cyproheptadine treatment.
Aronin N; Krieger DT
N Engl J Med; 1980 Feb; 302(8):453-5. PubMed ID: 6243392
[No Abstract] [Full Text] [Related]
[Next] [New Search]
